TradingAgents AISign inGet started
All stock profiles
VIVSNASDAQHealthcare

VIVOSIM LABS INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$0.15

-1.97%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze VIVS free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-26.2%

3 months

-53.7%

6 months

-89.2%

1 year

-94.8%

Year to date

-91.4%

52-week range

$0.15 – $2.98

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$2.3M

P/E

-0.2

P/B

-1

P/S

20.5

Revenue

$112K

Net income

-$12.34M

Diluted EPS

-4.47

Gross margin

100.00%

Net margin

-11016.10%

Return on equity

-612.20%

Total debt

$316K

Cash

$1.81M

Free cash flow

-$10.12M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$18K-$1.34M100.00%-7433.30%-$3.24M
Mar 31, 2026$40K-$5.76M100.00%-14410.00%-$2.24M
Dec 31, 2025$26K-$2.69M100.00%-10350.00%-$2.27M
Sep 30, 2025$28K-$2.55M100.00%-9089.30%-$2.38M
Jun 30, 2025$37K-$2.84M100.00%-7683.80%-$3.94M
Mar 31, 2025$51K$6.85M100.00%13435.30%$6.97M
Dec 31, 2024$24K-$3.45M91.70%-14362.50%-$1.8M
Sep 30, 2024$30K-$2.55M96.70%-8496.70%-$2.66M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent VIVS news

All market news

No ticker-linked stories are in the current archive.